Dr John Park

Clinical Lecturer
Westmead Clinical School


Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Da Silva, I., Wang, K., Wilmott, J., Holst, J., Carlino, M., Park, J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Rai, R., Kefford, R., Rizos, H., Scolyer, R., Yang, J., Long, G., Menzies, A., et al (2019). Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma. Clinical Cancer Research, 25(4), 1272-1279. [More Information]
  • Valpione, S., Carlino, M., Mangana, J., Mooradian, M., McArthur, G., Schadendorf, D., Hauschild, A., Menzies, A., Arance, A., Ascierto, P., Park, J., Long, G., et al (2018). Corrigendum to Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]". European Journal of Cancer, 93, 158. [More Information]
  • Park, J., Diefenbach, R., Joshua, A., Kefford, R., Carlino, M., Rizos, H. (2018). Oncogenic signaling in uveal melanoma. Pigment Cell & Melanoma Research, 31(6), 661-672. [More Information]
  • Valpione, S., Carlino, M., Mangana, J., Mooradian, M., McArthur, G., Schadendorf, D., Hauschild, A., Menzies, A., Arance, A., Ascierto, P., Park, J., Rai, R., Long, G., et al (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer, 91, 116-124. [More Information]
  • Menzies, A., Johnson, D., Ramanujam, S., Atkinson, V., Wong, A., Park, J., McQuade, J., Shoushtari, A., Tsai, K., Eroglu, Z., Guminski, A., Carlino, M., Long, G., et al (2017). Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Annals of Oncology, 28(2), 368-376. [More Information]
  • Sabanathan, D., Park, J., MARQUEZ, M., FRANCISCO, L., BYRNE, N., Gurney, H. (2017). Cure in advanced renal cell cancer: Is it an achievable goal? Clinical Genitourinary Cancer, 22(12), 1470-1477. [More Information]
  • Parakh, S., Park, J., Mendis, S., Rai, R., Xu, W., Lo, S., Drummond, M., Rowe, C., Wong, A., McArthur, G., Guminski, A., Kefford, R., Long, G., Menzies, A., Carlino, M., et al (2017). Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. British Journal of Cancer, 116(12), 1558-1563. [More Information]
  • Chia, K., Park, J., Postle, J., Cottrill, A., Ward, M. (2010). Frequency of Late Drug-Eluting Stent Thrombosis With Non-Cardiac Surgery. American Journal of Cardiology, 106(1), 1-3. [More Information]

2019

  • Da Silva, I., Wang, K., Wilmott, J., Holst, J., Carlino, M., Park, J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Rai, R., Kefford, R., Rizos, H., Scolyer, R., Yang, J., Long, G., Menzies, A., et al (2019). Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma. Clinical Cancer Research, 25(4), 1272-1279. [More Information]

2018

  • Valpione, S., Carlino, M., Mangana, J., Mooradian, M., McArthur, G., Schadendorf, D., Hauschild, A., Menzies, A., Arance, A., Ascierto, P., Park, J., Long, G., et al (2018). Corrigendum to Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]". European Journal of Cancer, 93, 158. [More Information]
  • Park, J., Diefenbach, R., Joshua, A., Kefford, R., Carlino, M., Rizos, H. (2018). Oncogenic signaling in uveal melanoma. Pigment Cell & Melanoma Research, 31(6), 661-672. [More Information]
  • Valpione, S., Carlino, M., Mangana, J., Mooradian, M., McArthur, G., Schadendorf, D., Hauschild, A., Menzies, A., Arance, A., Ascierto, P., Park, J., Rai, R., Long, G., et al (2018). Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. European Journal of Cancer, 91, 116-124. [More Information]

2017

  • Menzies, A., Johnson, D., Ramanujam, S., Atkinson, V., Wong, A., Park, J., McQuade, J., Shoushtari, A., Tsai, K., Eroglu, Z., Guminski, A., Carlino, M., Long, G., et al (2017). Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Annals of Oncology, 28(2), 368-376. [More Information]
  • Sabanathan, D., Park, J., MARQUEZ, M., FRANCISCO, L., BYRNE, N., Gurney, H. (2017). Cure in advanced renal cell cancer: Is it an achievable goal? Clinical Genitourinary Cancer, 22(12), 1470-1477. [More Information]
  • Parakh, S., Park, J., Mendis, S., Rai, R., Xu, W., Lo, S., Drummond, M., Rowe, C., Wong, A., McArthur, G., Guminski, A., Kefford, R., Long, G., Menzies, A., Carlino, M., et al (2017). Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. British Journal of Cancer, 116(12), 1558-1563. [More Information]

2010

  • Chia, K., Park, J., Postle, J., Cottrill, A., Ward, M. (2010). Frequency of Late Drug-Eluting Stent Thrombosis With Non-Cardiac Surgery. American Journal of Cardiology, 106(1), 1-3. [More Information]

To update your profile click here. For support on your academic profile contact .